Circle Pharma Appoints James Aggen, PhD as Its Vice President, Medicinal Chemistry
Circle adds experienced drug hunter Dr. James Aggen to its growing team as Vice President of Medicinal Chemistry.[...]
Circle adds experienced drug hunter Dr. James Aggen to its growing team as Vice President of Medicinal Chemistry.[...]
Renowned scientists Dr. Bruce Stillman and Dr. Alan Ashworth join Nobel laureate Dr. William Kaelin on Circle Pharma's Scientific Advisory Board.[...]
Circle Pharma Appoints Rajinder Singh, PhD as its Chief Science Officer[...]
Circle Pharma has appointed 2019 Nobel Laureate William G. Kaelin Jr., MD as its lead science advisor and chair of its SAB.[...]
Circle Pharma closes $45M series B financing led by The Column Group to support its macrocycle drug development work. [...]
Circle Pharma congratulates 2019 Nobel laureate Dr. Bill Kaelin. Dr. Kaelin advises Circle on its work to develop cyclin inhibitors for cancer., [...]
Results from its collaborative work with Pfizer to develop a potent and orally bioavailable macrocycle modulator have been published [...]
David Spellmeyer, PhD, has been appointed as Circle Pharma's chief scientific officer [...]
An expansion of Series A financing has been completed, with new investors W.I. Harper Group, [...]
Series A financing round has been announced in which over $4.5M of shares have been issued [...]